These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6931715)

  • 1. [Quantitative shifting of intra and peritumoral cell populations after intratumoral BCG-cell-wall therapy in squamous epithelial mouth neoplasms].
    Schlesinger S; Pickartz H; Bier J
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):118-20. PubMed ID: 6931715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative aspects of labeled plasma cell count in the demonstration of heavy and light immunoglobulin chains. (Findings in human oral squamous cell carcinomas before and after BCG treatment)].
    Jautzke G; Doering C
    Acta Histochem Suppl; 1982; 25():95-100. PubMed ID: 6806867
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
    Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial.
    Tímár J; Forster-Horváth C; Lukits J; Döme B; Ladányi A; Remenár E; Kásler M; Bencsik M; Répássy G; Szabó G; Velich N; Suba Z; Elõ J; Balatoni Z; Bajtai A; Chretien P; Talor E
    Laryngoscope; 2003 Dec; 113(12):2206-17. PubMed ID: 14660929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic anergy with septic shock after intratumoral injection of BCG cell wall preparation].
    Bier J
    Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(3):184-91. PubMed ID: 3868439
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of established oral tumors after intralesional injection of living BCG or BCG cell walls.
    Zbar B; Canti G; Rapp HJ; Bier J; Borsos T
    Cancer; 1979 Apr; 43(4):1304-7. PubMed ID: 376088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Qualitative and quantitative studies of the inflammatory reaction in the tumor boundary zone of intraoral squamous cell carcinomas].
    Epstude J; Müller P; Hyckel P; Schumann D
    Dtsch Zahn Mund Kieferheilkd Zentralbl; 1991; 79(6):483-9. PubMed ID: 1932438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of the inflammatory infiltrate associated with equine squamous cell carcinoma.
    Pérez J; Mozos E; Martín MP; Day MJ
    J Comp Pathol; 1999 Nov; 121(4):385-97. PubMed ID: 10542127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
    Tímár J; Ladányi A; Forster-Horváth C; Lukits J; Döme B; Remenár E; Godény M; Kásler M; Bencsik B; Répássy G; Szabó G; Velich N; Suba Z; Elo J; Balatoni Z; Pócza K; Zemplén B; Chretien P; Talor E
    J Clin Oncol; 2005 May; 23(15):3421-32. PubMed ID: 15908653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients.
    Diaz EM; Holsinger FC; Zuniga ER; Roberts DB; Sorensen DM
    Head Neck; 2003 Apr; 25(4):267-73. PubMed ID: 12658730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extracapsular lymph node metastasis in squamous cell carcinoma of the oral cavity after chemo-radio-surgical treatment protocol].
    Pomatto E; Berutto M; Vercellino V
    Minerva Chir; 1994 Jun; 49(6):565-8. PubMed ID: 7970061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reovirus oncolysis in human head and neck squamous carcinoma cells.
    Ikeda Y; Nishimura G; Yanoma S; Kubota A; Furukawa M; Tsukuda M
    Auris Nasus Larynx; 2004 Dec; 31(4):407-12. PubMed ID: 15571915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on immunotherapy in oral cancer patients with BCG and tumour antigens.
    Nir PN; Gangal SG; Rao RS
    Indian J Med Res; 1979 Aug; 70():252-62. PubMed ID: 521095
    [No Abstract]   [Full Text] [Related]  

  • 16. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
    Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression.
    Shieh YS; Lee HS; Shiah SG; Chu YW; Wu CW; Chang LC
    J Oral Pathol Med; 2004 Nov; 33(10):601-6. PubMed ID: 15482326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intratumorally administered mycobacterial cell walls in the treatment of cattle with ocular carcinoma.
    Kleinschuster SJ; Rapp HJ; Green SB; Bier J; van Kampen K
    J Natl Cancer Inst; 1981 Nov; 67(5):1165-71. PubMed ID: 6946252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.